Terns Pharmaceuticals, Inc. (TERN)
38.18
+0.20
(+0.53%)
USD |
NASDAQ |
Feb 10, 16:00
38.18
0.00 (0.00%)
After-Hours: 17:30
Terns Pharmaceuticals Shareholders Equity (Quarterly) : 284.07M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 631.90M |
| Ligand Pharmaceuticals, Inc. | 950.17M |
| ADMA Biologics, Inc. | 431.19M |
| Cidara Therapeutics, Inc. | 422.39M |
| Cogent Biosciences, Inc. | 302.46M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 301.65M |
| Total Liabilities (Quarterly) | 17.58M |
| Debt to Equity Ratio | 0.0036 |
| Current Ratio | 19.52 |
| Net Debt Paydown Yield | -0.02% |